Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06891222 · ClinicalTrials.gov registry record

A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening

A clinical trial of Cardiac Disease, sponsored by Mayo Clinic.

Recruiting
Registry status
10,500
Enrollment target
1
Study location

NCT06891222 is a study of Cardiac Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 10,500 participants, above the 385-participant average among 24 other Cardiac Disease trials with a reported enrollment target (2627% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06891222, a study of Cardiac Disease, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
10,500 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate and compare the effectiveness of active screening for SHD in asymptomatic outpatients referred for an ECG, using a combination of AI-ECG and FOCUS. Invites will be sent and participants enrolled electronically.

Conditions Studied

Cardiac Disease

Interventions

  • DIAGNOSTIC_TEST AI-ECG (artificial intelligence-enabled electrocardiogram)
  • DIAGNOSTIC_TEST Focus Screening (focused cardiac ultrasonography)

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 10,500 participants
Start Date 2025-04-14
Est. Completion 2026-04

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06891222

The ClinicalTrials.gov registry entry for NCT06891222 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 385-participant average among 24 other Cardiac Disease trials with a reported enrollment target (2627% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiac Disease appearing as the primary indexed condition, and to 2 interventions - of which AI-ECG (artificial intelligence-enabled electrocardiogram) is the first listed.

NCT06891222 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06891222 about?

NCT06891222 is a clinical study titled "A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening". The purpose of this study is to evaluate and compare the effectiveness of active screening for SHD in asymptomatic outpatients referred for an ECG, using a combination of AI-ECG and FOCUS. Invites will be sent and participants enrolled electronically.

What is the current status of trial NCT06891222?

This trial is currently recruiting. The enrollment target is 10,500 participants. The study started on 2025-04-14. Estimated completion is 2026-04.

What conditions does trial NCT06891222 study?

This clinical trial studies the following conditions: Cardiac Disease.

What interventions are being tested in trial NCT06891222?

The interventions under investigation include: AI-ECG (artificial intelligence-enabled electrocardiogram) (DIAGNOSTIC_TEST), Focus Screening (focused cardiac ultrasonography) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06891222?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06891222 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cardiac Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cardiac Disease

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.